Skip to content

Carlyle Group Inc.

Follow

13F filer, CIK 1527166, WASHINGTON, DC

Carlyle Group Inc. reported $5,032,012,385 across 20 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-08. Its ten largest share positions make up 99.72% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000898432-25-000575

Period
2025-06-30
Reported value
$5.03B
Holdings
20
Top 10 weight
99.72%
New
2
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SAROadded+18,321,061$580M
FWRDnew+107,214$2.95M
HOODnew+2,497$234K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
WRDexited-3,423,023-$46.5M
SMHIexited-1,355,761-$6.86M
FORWARD AIR CORPexited-107,214-$2.67M
SPRUCE BIOSCIENCES INCexited-2,896,518-$840K
SPWRreduced-397,041-$731K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000898432-25-000575, largest first. % of portfolio is the value over $5,032,012,385, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SAROSTANDARDAERO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 6,675,862 shares; 2025Q1: 134,352,830 shares; 2025Q2: 152,673,891 shares 152,673,891$4.83B96.03%+18,321,061Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,071,562 shares; 2024Q4: 1,375,646 shares; 2025Q1: 860,980 shares; 2025Q2: 860,980 shares 860,980$72.1M1.43%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,496,808 shares; 2024Q4: 3,496,808 shares; 2025Q1: 3,496,808 shares; 2025Q2: 3,496,808 shares 3,496,808$33.5M0.67%0Timeline
PONYPONY AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,362,447 shares; 2025Q1: 2,362,447 shares; 2025Q2: 2,362,447 shares 2,362,447$31.2M0.62%0Timeline
INVHINVITATION HOMES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 477,500 shares; 2024Q4: 477,500 shares; 2025Q1: 477,500 shares; 2025Q2: 477,500 shares 477,500$15.7M0.31%0Timeline
GETYGETTY IMAGES HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,212,799 shares; 2024Q4: 8,684,599 shares; 2025Q1: 6,234,252 shares; 2025Q2: 6,234,252 shares 6,234,252$10.3M0.21%0Timeline
CUBECUBESMARTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 220,500 shares; 2024Q4: 220,500 shares; 2025Q1: 220,500 shares; 2025Q2: 220,500 shares 220,500$9.37M0.19%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,066,189 shares; 2024Q4: 1,066,189 shares; 2025Q1: 1,066,189 shares; 2025Q2: 1,066,189 shares 1,066,189$5.92M0.12%0Timeline
EMSMART SH GLOBAL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,810,209 shares; 2024Q4: 4,810,209 shares; 2025Q1: 4,362,929 shares; 2025Q2: 3,807,399 shares 3,807,399$4.34M0.09%-555,530Timeline
HILLEVAX INCHILLEVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,838,486 shares; 2024Q4: 1,838,486 shares; 2025Q1: 1,838,486 shares; 2025Q2: 1,838,486 shares 1,838,486$3.59M0.07%0
FWRDFORWARD AIR CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 107,214 shares 107,214$2.95M0.06%newTimeline
SPWRSUNPOWER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,901,340 shares; 2024Q4: 1,984,619 shares; 2025Q1: 1,984,508 shares; 2025Q2: 1,587,467 shares 1,587,467$2.92M0.06%-397,041Timeline
XCUREXICURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 56,328 shares; 2024Q4: 281,636 shares; 2025Q1: 281,636 shares; 2025Q2: 281,636 shares 281,636$1.93M0.04%0Timeline
ADICET BIO INCADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,948,718 shares; 2024Q4: 2,948,718 shares; 2025Q1: 2,948,718 shares; 2025Q2: 2,948,718 shares 2,948,718$1.8M0.04%0
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,102,741 shares; 2024Q4: 1,102,741 shares; 2025Q1: 1,102,741 shares; 2025Q2: 1,102,741 shares 1,102,741$1.62M0.03%0Timeline
DNUTKRISPY KREME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 340,748 shares; 2024Q4: 340,748 shares; 2025Q1: 340,748 shares; 2025Q2: 340,748 shares 340,748$992K0.02%0Timeline
NABLN-ABLE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,732 shares; 2024Q4: 93,732 shares; 2025Q1: 93,732 shares; 2025Q2: 93,732 shares 93,732$759K0.02%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 269,895 shares; 2025Q1: 269,895 shares; 2025Q2: 269,895 shares 269,895$642K0.01%0Timeline
HOODROBINHOOD MKTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 6,242 shares; 2025Q1: not reported; 2025Q2: 2,497 shares 2,497$234K<0.01%newTimeline
NuCana PLCNuCana PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 133,333 shares; 2024Q4: 133,333 shares; 2025Q1: 133,333 shares; 2025Q2: 133,333 shares 133,333$7.64K<0.01%0

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
WRDWERIDE INC3,423,023$46.5Mshares
SMHISEACOR MARINE HLDGS INC1,355,761$6.86Mshares
FORWARD AIR CORPFORWARD AIR CORP107,214$2.67Mshares
SPRUCE BIOSCIENCES INCSPRUCE BIOSCIENCES INC2,896,518$840Kshares
CARTMAPLEBEAR INC5,479$219Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000898432-25-000575 base2025-08-08acceptance time not in the bulk data set